Project I: Systems analysis of tumor-stroma interactions in brain metastasis
项目一:脑转移中肿瘤-基质相互作用的系统分析
基本信息
- 批准号:10525192
- 负责人:
- 金额:$ 53.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-16 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Adenocarcinoma CellAlzheimer&aposs DiseaseApoptosisAstrocytesBasement membraneBindingBrainBreast Cancer CellCancer PatientCell CommunicationCellsClinicalCommunicationComplexDisease associated microgliaDisseminated Malignant NeoplasmERBB2 geneExtracellular Matrix ProteinsFactor AnalysisGene ExpressionGenesGeneticGenetic TranscriptionGoalsGrowthHomeostasisImmuneImmune systemImmunologistLabelLamininLeadLearningLogicLung AdenocarcinomaMalignant NeoplasmsMalignant neoplasm of lungMediatingMediator of activation proteinMemorial Sloan-Kettering Cancer CenterMetastatic malignant neoplasm to brainMicrogliaModelingMorbidity - disease rateNatural ImmunityNatureNeoplasm MetastasisNeural Cell Adhesion Molecule L1PF4 GenePatientsPharmacologyPhenotypePhysiciansPrimary NeoplasmResearchResearch PersonnelResistanceSamplingShapesSignal TransductionSupervisionSystemSystems AnalysisSystems BiologyTestingTherapeutic InterventionTissuesTranscriptional Regulationautocrinebrain cellbrain shapecancer cellcell typecerebral capillarydifferential expressionknowledge of resultslung colonizationmalignant breast neoplasmmortalitymouse modelmultiple omicspreventprogramsresponsesingle cell analysissingle-cell RNA sequencingspatial relationshipspatiotemporaltherapeutic developmenttherapeutic evaluationtriple-negative invasive breast carcinomatumortumor growthtumor microenvironmentunpublished works
项目摘要
Project I. Systems Analysis of Tumor-Stroma Interactions in Brain Metastasis
Experimental Lead: Massagué
Computational Lead: Pe’er
PROJECT SUMMARY
The overall goal of this project is to apply systems-level computational approaches to mouse models and clinical
samples to unravel strategies that metastatic cancer cells employ to colonize the brain. Brain metastasis is a
major cause of morbidity and mortality in breast and lung cancer patients. The Massagué Lab pioneered studies
to identify mediators of brain metastasis and relevant cell-cell interactions, and are subjecting this problem to
systems-level analysis with the Pe’er Lab. We recently found that brain metastatic lesions of triple-negative
breast cancer (TNBC), HER2+ breast cancer (HER2BC), and lung adenocarcinoma (LUAD) in mouse models
and patient samples display remarkable differences in the spatial relationship between cancer cells and the host
tissue. TNBC and LUAD cells spread along brain capillaries via L1CAM, forming perivascular colony networks
that intermingle with microglia and astrocytes. In sharp contrast, HER2BC cells colonize the brain by forming
compact spheroidal colonies that exclude brain parenchymal cells. High expression of specific extracellular
matrix proteins by HER2BC cells drives this spheroidal growth. Notably, the perivascular and spheroidal colonies
trigger distinct disease-associated microglia (DAM) innate immunity stages previously defined in Alzheimer’s
disease. Aim 1 is to elucidate the DAM regulatory mechanisms in metastasis-associated microglia. We
will resolve transcriptional regulation of the homeostasis-to-DAM transition in brain metastasis by analyzing
single-cell multiomic profiles of metastasis-associated microglia. We will dissect how cancer cells trigger and
modulate DAM responses by testing the hypothesis that HER2BC apoptosis triggers stage 2 DAM, whereas
enhanced survival of TNBC retains stage 1 DAM. We will identify drivers of TNBC-intrinsic resistance to
apoptosis by computationally guided search for autocrine pro-survival signaling in TNBC cells. We will determine
how stage 1 DAM supports tumor growth. We will seek to connect metastasis-associated microglia to activated
microglia states across contexts by supervised gene set analysis. Aim 2 is to define spatiotemporal
progression and multicellular communication in brain metastasis by a systems-level analysis. We and
others have shown the engagement of multiple cell types besides microglia to support brain metastasis. These
interactions call for a comprehensive interrogation of the various ensembles of multicellular communication that
shape brain metastasis. We will leverage our LUAD-to-brain metastasis models to study “what” cell types and
programs constitute multicellular communication ensembles. We will analyze intact metastatic colonies to learn
“where” the cells are localized and which programs are differentially expressed. We will unravel “how” the cells
and programs shape metastasis by computationally inferring the formation and impact of multicellular ensembles
from snapshots of metastatic colonies. We will perturb the inferred ensembles to test therapeutic intervention
paradigms. The resulting knowledge, enriched with the input of the CSBC Research Center immunologists and
physicians, will ultimately guide the development of therapeutic interventions to target brain metastases.
1
项目I.脑转移中肿瘤 - 细胞瘤相互作用的系统分析
实验铅:马萨吉
计算铅:pe'er
项目摘要
该项目的总体目标是将系统级计算方法应用于鼠标模型和临床
样品揭示了转移性癌细胞的策略,使大脑定居。脑转移是
乳腺癌和肺癌患者发病率和死亡率的主要原因。 Massagué实验室开创性研究
确定脑转移的介体和相关的细胞 - 细胞相互作用,并将此问题置于
使用PE'ER实验室的系统级分析。我们最近发现三阴性的脑转移性病变
小鼠模型中的乳腺癌(TNBC),HER2+乳腺癌(HER2BC)和肺腺癌(LUAD)
患者样品在癌细胞与宿主之间的空间关系上显示出显着差异
组织。 TNBC和LUAD细胞通过L1CAM沿着脑毛细血管扩散,形成血管周菌落网络
与小胶质细胞和星形胶质细胞相结合。形成鲜明的对比,HER2BC细胞通过形成大脑定居
紧凑的球体菌落排除了脑实质细胞。特定细胞外的高表达
HER2BC细胞的基质蛋白驱动该球体生长。值得注意的是,血管周围和球形菌落
触发与先前在阿尔茨海默氏症中定义的不同的疾病相关的小胶质细胞(DAM)先天免疫学阶段
疾病。目的1是阐明与转移相关的小胶质细胞中的大坝调节机制。我们
通过分析,将解决脑转移中体内稳态到达元过渡的转录调节
转移相关小胶质细胞的单细胞多素谱。我们将剖析癌细胞的触发方式和
通过测试HER2BC凋亡触发2阶段大坝的假设来调节大坝的反应,而
TNBC的生存增强保留了1阶段的大坝。我们将确定TNBC intrinsic抗性的驱动因素
通过计算指导搜索TNBC细胞中的自分泌促生存信号传导的细胞凋亡。我们将确定
第1阶段水坝如何支持肿瘤生长。我们将寻求将转移相关的小胶质细胞与激活联系起来
小胶质细胞通过监督基因集分析在环境中循环。目标2是定义时空
通过系统级分析,脑转移中的进展和多细胞通信。我们和
其他人则表明,除了小胶质细胞以外,多种细胞类型的参与以支持脑转移。这些
互动要求对多细胞沟通的各种集合进行全面审问
塑造脑转移。我们将利用我们的luad到脑转移模型来研究“什么”细胞类型和
程序构成多细胞通信合奏。我们将分析完整的转移菌落以学习
“位置”单元格位于本地化,并且表达了哪些程序。我们将揭开“细胞”的“如何”
程序和程序通过计算上推断多细胞合奏的形成和影响来塑造转移
来自转移菌落的快照。我们将扰动推断的合奏来测试治疗干预
范式。由CSBC研究中心免疫学家和
医师最终将指导理论干预措施以靶向脑转移的发展。
1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOAN MASSAGUE其他文献
JOAN MASSAGUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOAN MASSAGUE', 18)}}的其他基金
Project I: Systems analysis of tumor-stroma interactions in brain metastasis
项目一:脑转移中肿瘤-基质相互作用的系统分析
- 批准号:
10705775 - 财政年份:2022
- 资助金额:
$ 53.39万 - 项目类别:
The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
发育和癌症中的 TGF 信号通路
- 批准号:
10683414 - 财政年份:2020
- 资助金额:
$ 53.39万 - 项目类别:
The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
发育和癌症中的 TGF 信号通路
- 批准号:
10238832 - 财政年份:2020
- 资助金额:
$ 53.39万 - 项目类别:
The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
发育和癌症中的 TGF 信号通路
- 批准号:
10473733 - 财政年份:2020
- 资助金额:
$ 53.39万 - 项目类别:
Residual disease: unraveling immunosurveillance and immune evasion of disseminated tumor cells
残留疾病:解开播散性肿瘤细胞的免疫监视和免疫逃避
- 批准号:
9980810 - 财政年份:2016
- 资助金额:
$ 53.39万 - 项目类别:
Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer
TGF-β抑瘤乳腺癌的转移和逃避机制
- 批准号:
7438485 - 财政年份:2008
- 资助金额:
$ 53.39万 - 项目类别:
Project 1: Mediators of Lung Adenocarcinoma Metastatis
项目1:肺腺癌转移的介质
- 批准号:
10246296 - 财政年份:2007
- 资助金额:
$ 53.39万 - 项目类别:
相似海外基金
Developing new therapeutic strategies for brain metastasis
开发脑转移的新治疗策略
- 批准号:
10578405 - 财政年份:2023
- 资助金额:
$ 53.39万 - 项目类别:
Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease
沉默星形细胞 MAGL 作为阿尔茨海默病的治疗方法
- 批准号:
10633381 - 财政年份:2023
- 资助金额:
$ 53.39万 - 项目类别:
Project I: Systems analysis of tumor-stroma interactions in brain metastasis
项目一:脑转移中肿瘤-基质相互作用的系统分析
- 批准号:
10705775 - 财政年份:2022
- 资助金额:
$ 53.39万 - 项目类别:
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
发现一流的 WDR5 PROTAC 作为 MLL 重排白血病的新型治疗策略
- 批准号:
10712396 - 财政年份:2022
- 资助金额:
$ 53.39万 - 项目类别:
Determining the role of myeloid cells in establishing the pre-metastatic niche in pancreatic cancer
确定骨髓细胞在建立胰腺癌转移前生态位中的作用
- 批准号:
10063306 - 财政年份:2020
- 资助金额:
$ 53.39万 - 项目类别: